Fresh off the acquisition of metabolic medicines developer Metsera, Pfizer is again turning to dealmaking to expand its obesity drug pipeline, this time picking up an experimental oral ...
Regeneron Pharmaceuticals is committing $150 million to begin an alliance on a Tessera Therapeutics gene-editing medicine nearing the clinic as a potential treatment for a rare disease ...
https://www.youtube.com/watch?v=DHOgteC4yX0
David Baszucki (@DavidBaszucki) is the co-founder and CEO of Roblox. TIME named Roblox one of the “100 Most Influential Companies,” and it has ...
Please enjoy this transcript of my interview with David Baszucki (@DavidBaszucki), the founder and CEO of Roblox. TIME named Roblox one of the “100 Most Influential Companies,” and it has been ...